WaferiX

iX Biopharma enters agreement with Chinese pharmaceutical distributor to tap China market - THE EDGE SINGAPORE

Deals, joint ventures & alliances

iX Biopharma enters agreement with Chinese pharmaceutical distributor to tap China market

Specialty pharmaceutical company iX Biopharma has entered into a strategic cooperation framework agreement with China Resources Pharmaceutical Commercial Group Co (CRPCG) to collaborate o

Broker's Calls

Phillip Securities initiates 'buy' for iX Biopharma on prospect of turning profitable in FY21

Phillip Securities has initiated coverage on iX Biopharma with a “buy” recommendation and target price of 45.5 cents.

iX Biopharma secures Israel patent for WaferiX - THE EDGE SINGAPORE

Company in the news

iX Biopharma secures Israel patent for WaferiX

iX Biopharma has been granted a patent in Israel for its WaferiX drug delivery technology.

ix biopharma

Company in the news

iX Biopharma enters China market with licensing agreement for erectile dysfunction drug

SINGAPORE (Apr 27): iX Biopharma has entered into a 10-year licensing agreement with Yiling Pharmaceutical in China for the licensing, supply, and distribution of Wafesil, a fast-dissolvi

iXBiopharma's Wafesil granted regulatory approval for treatment of male erectile dysfunction in Australia

SINGAPORE (June 19): iX Biopharma says the Australia’s regulatory authority, Therapeutic Goods Administration (TGA), has given the go-ahead for the use of Wafesil to treat of male erectile dysfunct

iX Biopharma secures European patent for drug delivery technology

SINGAPORE (Oct 23): Specialty pharmaceutical firm iX Biopharma announced Monday that it has secured a European patent for its WaferiX drug delivery technology.

iX Biopharma’s WaferiX granted South Africa patent

SINGAPORE (Nov 21): Pharmaceutical company iX Biopharma announced that it has been granted a patent in South Africa for its WaferiX drug delivery technology.

iX Biopharma secures Canadian patent for WaferiX

SINGAPORE (Oct 31): iX Biopharma announced that it has secured a Canadian patent for its WaferiX drug delivery technology.

In print this week

Why are investors cool to the stocks of these two innovative medtech firms?

SINGAPORE (Aug 26): iX Biopharma is a small Catalist-listed Singapore company focusing on a big goal: Developing pain management drugs that are an alternative to opioids, and the optimum system to

South Korea grants patent to iX Biopharma's technology

SINGAPORE (June 9): South Korea is the latest country to grant a patent to iX Biopharma’s WaferiX drug delivery technology, says the pharmaceutical firm on Thursday.

×